Equity (Tables)
|
3 Months Ended |
May 02, 2026 |
| Equity [Abstract] |
|
| Schedule of Reserved Shares of Common Stock for Future Issuance |
The Company had reserved shares of common stock for future issuance as of May 2, 2026 and January 31, 2026, as follows: | | | | | | | | | | | | | As of | | May 2, 2026 | | January 31, 2026 | | | | | | 2015 Equity Incentive Plan: | | | | | Options outstanding | 5,396,988 | | 5,406,188 | | | | | | | | | | 2021 Equity Incentive Plan: | | | | | RSUs outstanding | 21,744,310 | | 17,331,045 | | Shares available for future grants | 132,558,701 | | 109,926,401 | | 2021 Employee Stock Purchase Plan: | | | | | Shares available for future issuance | 31,842,089 | | 26,034,934 | | Total shares of common stock reserved for future issuance | 191,542,088 | | 158,698,568 |
|
| Schedule of Stock Options Activity |
The stock options activity under the 2015 Plan during the three months ended May 2, 2026 was as follows (the number of options represents shares of common stock exercisable in respect thereof): | | | | | | | | | | | | | | | | | | | | | | | | | Number of Shares | | Weighted-Average Exercise Price | | Weighted-Average Remaining Contractual Term (in years) | | Aggregate Intrinsic Value (1) (in thousands) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance as of January 31, 2026 | 5,406,188 | | $ | 5.62 | | 4.0 | | $ | 121,266 | | Granted | — | | $ | — | | | | | | Exercised | (9,200) | | $ | 1.16 | | | | | | Forfeited, canceled, or expired | — | | $ | — | | | | | | Balance as of May 2, 2026 | 5,396,988 | | $ | 5.63 | | 3.7 | | $ | 134,187 | | Exercisable as of May 2, 2026 | 5,396,988 | | $ | 5.63 | | 3.7 | | $ | 134,187 |
__________ (1)Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s Class A common stock for each period end presented, multiplied by the number of stock options outstanding or exercisable as of each period end presented.
|
| Schedule of RSU Activity |
A summary of the RSUs activity under the 2015 Plan and 2021 Plan during the three months ended May 2, 2026 is presented below: | | | | | | | | | | | | | Number of Shares | | Weighted-Average Grant-Date Fair Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance as of January 31, 2026 | 17,331,045 | | $ | 31.53 | | Granted | 9,078,938 | | $ | 31.96 | | Vested | (3,033,076) | | $ | 24.62 | | Forfeited | (1,632,597) | | $ | 32.33 | | Balance as of May 2, 2026 | 21,744,310 | | $ | 32.61 |
|
| Schedule of Stock-Based Compensation Expense |
Stock-based compensation expense, by grant type, was as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | | | | | May 2, 2026 | | May 3, 2025 | | | | | | | | | | | | | | RSUs | | | | | 74,258 | | 74,062 | | | | Employee stock purchase plan | | | | | 3,213 | | 3,017 | | | | Total stock-based compensation expense | | | | | $ | 77,471 | | $ | 77,079 | | |
Stock-based compensation expense included in the following line items of the Company’s condensed consolidated statements of operations and comprehensive income (loss) was as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | | | | | May 2, 2026 | | May 3, 2025 | | | | Cost of revenue | | | | | $ | 3,563 | | $ | 3,247 | | | | Research and development | | | | | 30,010 | | 27,020 | | | | Sales and marketing | | | | | 23,172 | | 23,548 | | | | General and administrative | | | | | 20,726 | | 23,264 | | | | Total stock-based compensation expense | | | | | $ | 77,471 | | $ | 77,079 | | |
|